CSS
FRTX

Cubist Systematic Strategies’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Cubist Systematic Strategies’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,125
Closed -$7.1K – 4150
2023
Q2 		$7.1K Sell
10,125
-3,517
-26% -$2.14K ﹤0.01% 3283
2023
Q1 		$9K Buy
+13,642
New +$22.8K ﹤0.01% 3730

Other funds holding FRTX

JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cubist Systematic Strategies's FRTX Position: Q3 2023 in Review

Cubist Systematic Strategies sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q3 2023, closing a stake of 10,125 shares — an estimated $7.1K sold.

Cubist Systematic Strategies first reported a position in FRTX in Q1 2023 and held it in 2 quarters. The position peaked at $9K in Q1 2023. 15 funds tracked by Wall St. Rank hold FRTX as of Q3 2023.

  • Cubist Systematic Strategies reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 10,125 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $7.1K.
  • Cubist Systematic Strategies first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
  • Cubist Systematic Strategies's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $9K in Q1 2023.
  • 15 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Cubist Systematic Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.